News
Eli Lilly’s Mounjaro gets marketing approval for weight-loss and diabetes treatment in India
US pharma giant Eli Lilly has secured Indian regulatory approval to market Mounjaro, its widely used diabetes and weight-loss drug. Available in six dosages, Mounjaro helps manage type 2 diabetes and chronic obesity by regulating blood sugar and appetite.
Eli Lilly's obesity and Type 2 diabetes drug, Mounjaro, has gained approval from the Indian drug control authority for its ...
India's obesity drug market is set for intense competition with Novo Nordisk launching Wegovy to challenge Eli Lilly's ...
6don MSN
Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...
Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback